Literature DB >> 9186326

Immunohistochemical description of nitric oxide synthase isoforms in human clitoris.

A L Burnett1, D C Calvin, R I Silver, D S Peppas, S G Docimo.   

Abstract

PURPOSE: Our aim was to identify and localize nitric oxide synthase isoforms in the human clitoris in support of the hypothesis that nitric oxide mediates erectile function in this organ.
MATERIALS AND METHODS: Nitric oxide synthase immunohistochemistry studies specific for neuronal, inducible and endothelial isoforms of the enzyme were performed on human clitoral tissue obtained from 4 patients (3 with female pseudohermaphroditism and 1 with true hermaphroditism) at feminizing genitoplasty and from 1 phenotypically normal woman at autopsy.
RESULTS: Neuronal nitric oxide synthase immunoreactivity was detected in nerve bundles and fibers coursing within the glans clitoris and corpora cavernosa of the clitoris, predominating in the latter tissue. Specific inducible nitric oxide synthase immunoreactivity was not identified. Endothelial nitric oxide synthase immunoreactivity was detected in vascular and sinusoidal endothelium of these tissues with a predominance in the glans clitoris.
CONCLUSIONS: The presence and anatomical localizations of nitric oxide synthase isoforms in the human clitoris indicate that nitric oxide is generated in this organ. These data suggest that nitric oxide may be involved in the erectile physiology of the clitoris as a modulator of clitoral smooth muscle activity. Functional studies are required to support this hypothesis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9186326     DOI: 10.1097/00005392-199707000-00020

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  21 in total

Review 1.  NO as a signalling molecule in the nervous system.

Authors:  Juan V Esplugues
Journal:  Br J Pharmacol       Date:  2002-03       Impact factor: 8.739

2.  PDE-5 and NOS II mRNA expression in menopausal women: a molecular biology study.

Authors:  Gianna Pace; Paola Palumbo; Gianfranca Miconi; Vania Silvestri; Maria Grazia Cifone; Carlo Vicentini
Journal:  World J Urol       Date:  2010-02-23       Impact factor: 4.226

3.  Protein kinase enzymes in the human vagina-relation to key mediators of the cyclic AMP and cyclic GMP pathways.

Authors:  S Ückert; J Sonnenberg; J E Sonnenberg; W Kauffels; K Albrecht; M A Kuczyk; P Hedlund
Journal:  Int J Impot Res       Date:  2017-04-13       Impact factor: 2.896

4.  Histotopography of the female cavernous nerve: a study using donated fetuses and adult cadavers.

Authors:  Masao Kato; Hitoshi Niikura; Nobuo Yaegashi; Gen Murakami; Haruyuki Tatsumi; Akio Matsubara
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2008-09-19

Review 5.  The Female Sexual Response: Current Models, Neurobiological Underpinnings and Agents Currently Approved or Under Investigation for the Treatment of Hypoactive Sexual Desire Disorder.

Authors:  Sheryl A Kingsberg; Anita H Clayton; James G Pfaus
Journal:  CNS Drugs       Date:  2015-11       Impact factor: 5.749

6.  The effect of sildenafil citrate on uterine and clitoral arterial blood flow in postmenopausal women.

Authors:  Erkan Alatas; A Baki Yagci
Journal:  MedGenMed       Date:  2004-10-13

Review 7.  Impact of Immune System Activation and Vascular Impairment on Male and Female Sexual Dysfunction.

Authors:  Fabiano B Calmasini; Nicole Klee; R Clinton Webb; Fernanda Priviero
Journal:  Sex Med Rev       Date:  2019-07-17

8.  Neurologic factors in female sexual function and dysfunction.

Authors:  Kazem M Azadzoi; Mike B Siroky
Journal:  Korean J Urol       Date:  2010-07-20

9.  Impact of phosphodiesterase type 5 inhibitors on endothelial function.

Authors:  Patrick E Teloken; John P Mulhall
Journal:  Rev Urol       Date:  2008

10.  The inhibitory effects of nicotine on physiological sexual arousal in nonsmoking women: results from a randomized, double-blind, placebo-controlled, cross-over trial.

Authors:  Christopher B Harte; Cindy M Meston
Journal:  J Sex Med       Date:  2008-03-04       Impact factor: 3.802

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.